1 of 5000

|

metal prints activity metal prints acute metal prints adult metal prints antibodies metal prints antibody metal prints antigen metal prints bites metal prints cancer metal prints cell metal prints combines metal prints cytotoxic metal prints drug metal prints illustration metal prints leukemia metal prints linking metal prints

photographs activity photos acute photos adult photos antibodies photos antibody photos antigen photos bites photos cancer photos cell photos combines photos cytotoxic photos drug photos illustration photos leukemia photos linking photos

Add This Artwork to Your Favorites Collection

Comment

Add This Artwork to Your Favorites Collection

Comment

Schematic computer artwork of the monoclonal antibody Blinatumomab, a bi-specific T-cell engager (BiTE). Blinatumomab (trade name) specifically targets the CD19 antigen present on B cells. Blinatumomab enables a patient's T cells to recognize malignant B cells. A molecule of blinatumomab combines two binding sites: a CD3 site for T cells and a CD19 site for the target B cells. CD3 is part of the T cell receptor. The drug works by linking these two cell types and activating the T cell to exert cytotoxic activity on the target cell.Blinatumomab is used as a second-line treatment against acute lymphoblastic leukemia. The background is depicting a cancer cell.

Science Photo Library (SPL) is the leading source of science images and footage. Sourced from scientific and medical experts, acclaimed photographers and renowned institutions, our content is unrivaled worldwide. Outstanding quality, accuracy and commitment to excellence are deeply embedded in our DNA. Science Photo Library inspires creative professionals and delivers engaging content of the highest quality for a wide range of clients in a variety of sectors. Visit sciencephoto.com for more information and stay connected on Twitter, LinkedIn, Instagram and Vimeo.